Therefore, anti-miR-21 therapy might not only act on tumor cells but also re-polarize tumor-associated macrophages towards an anti-tumor (M1) phenotype by preventing miR-21’s suppression of STAT1/NF-κB signaling in those immune cells [115]. Here, NFKB1 is linked to neoplasm.